SCHEMBL578140

SCHEMBL578140

Oc1cc(-c2c[nH]nc2Cc2ccccc2)nc(-c2nc(C(F)(F)F)cs2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
IDH1 O75874 3/20 0.34
PTGES O14684 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
RAB9A P51151 2/20 0.32
TTR P02766 1/20 0.32
NPC1 O15118 1/20 0.32
PAX8 Q06710 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
FABP4 P15090 1/20 0.31
ALK Q9UM73 1/20 0.31
HDAC4 P56524 1/20 0.31
MEF2D Q14814 1/20 0.31
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL578318 0.87 IDH1 (0.36) LMNAPOLBIDH1PTGES
SCHEMBL578259 0.81 IDH1 (0.35) LMNAPOLBIDH1PTGES
SCHEMBL11905052 0.74 IDH1 (0.42) LMNAPOLBIDH1PTGESMEN1
SCHEMBL15215580 0.73 KDM4E (0.36) LMNAPOLBMEN1KMT2AKDM4E
SCHEMBL578139 0.73 L3MBTL1 (0.43) ADORA2AADORA1SMN1; SMN2
SCHEMBL578111 0.71 IDH1 (0.46) LMNAPOLBIDH1FABP4
SCHEMBL577156 0.71 HSD17B1 (0.42) LMNAPOLBMEN1KMT2ARAB9A
SCHEMBL577784 0.70 IDH1 (0.36) LMNAPOLBIDH1PTGESKDM4E
SCHEMBL578086 0.70 IDH1 (0.36) LMNAPOLBIDH1PTGES
SCHEMBL578160 0.70 BLM (0.48) POLBIDH1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP disclosed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 EP disclosed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO disclosed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed